GGrantIndex
← Search

CLINICAL APPLICABILITY AND IMPROVED EFFICACY OF A CMV-VECTORED VACCINE IN A HETEROGENEOUS SPONTANEOUS HER2+ TUMOR MODEL

$739,409FY2021Defense Health AgencyDOD

Oregon Health & Science University, Portland OR

Investigators

View source on USAspending →
CLINICAL APPLICABILITY AND IMPROVED EFFICACY OF A CMV-VECTORED VACCINE IN A HETEROGENEOUS SPONTANEOUS HER2+ TUMOR MODEL · GrantIndex